Arkolith/Insider Trading/AURA/Form 4

Elazzouzi Amy

Senior Vice President, FinanceAura Biosciences, Inc. (AURA) · full profile →Form 4 · filed Aug 18, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$52K
Net Open-Market Flow
-$52K
Transactions
15
8 non-derivative · 7 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 18, 2025Option exercise(M)2K$4.25$10K94K
Aug 18, 2025Option exercise(M)1K$5.48$6K85K
Aug 18, 2025Option exercise(M)547$5.21$3K86K
Aug 18, 2025Option exercise(M)547$5.48$3K86K
Aug 18, 2025Option exercise(M)5K$2.74$13K91K
Aug 18, 2025Sell(S)8K$6.70$52K87K
Aug 18, 2025Option exercise(M)3K$5.07$13K84K
Aug 18, 2025Option exercise(M)1K$3.16$3K92K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 18, 2025Option exercise(M)1K—$00
Aug 18, 2025Option exercise(M)547—$00
Aug 18, 2025Option exercise(M)5K—$00
Aug 18, 2025Option exercise(M)1K—$00
Aug 18, 2025Option exercise(M)2K—$00
Aug 18, 2025Option exercise(M)3K—$00
Aug 18, 2025Option exercise(M)547—$00

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-109767) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML